Somerset Theraps Llc Company Profile
What is the competitive landscape for SOMERSET THERAPS LLC
SOMERSET THERAPS LLC has ninety-five approved drugs.
Summary for Somerset Theraps Llc
| US Patents: | 0 |
| Tradenames: | 85 |
| Ingredients: | 84 |
| NDAs: | 95 |
Drugs and US Patents for Somerset Theraps Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | TOFACITINIB CITRATE | tofacitinib citrate | TABLET;ORAL | 220137-002 | Jun 3, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | LACOSAMIDE | lacosamide | SOLUTION;INTRAVENOUS | 214960-001 | Oct 9, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | INJECTABLE;INJECTION | 090664-001 | Nov 17, 2009 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 207636-004 | Jun 15, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
